Shuttle Pharmaceuticals Inc (SHPH)

Name: Shuttle Pharmaceuticals Inc (SHPH) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Shuttle Pharmaceuticals Inc (SHPH)

Stock Card

$3.54

$-0.34 (-8.76%)

As on 28-Aug-2026 16:00EDT

Market cap

$2 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

37.6

P/B Ratio

0.7

Div. Yield

0 %

Shuttle Pharmaceuticals Inc (SHPH) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.51 High: 3.70

52 Week Range

Low: 2.58 High: 55.90

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-3.3 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

-0.7
Debt to Equity

0
Book Value

$--
EPS

$-60.6
Face value

--
Shares outstanding

585,129

9 Years Aggregate

CFO

$-9.72 Mln

EBITDA

$-10.18 Mln

Net Profit

$-11.74 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Shuttle Pharmaceuticals Inc (SHPH)	-80.3	21.2	-31.9	-89.4	-86.4	--	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023
Shuttle Pharmaceuticals Inc (SHPH)	-91.6	-76.1	-76.8
S&P Small-Cap 600	4.0	7.0	13.9
BSE Sensex	9.1	8.1	18.7

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Shuttle Pharmaceuticals Inc (SHPH)	3.5	2.2	0.0	-10.8	--	-456.5	37.6	0.7
Amneal Pharmaceuticals Inc Class A (AMRX)	17.6	6,238.0	3,117.6	157.4	14.7	--	37.3	188.9
Axsome Therapeutics (AXSM)	200.5	10,883.2	776.6	-191.6	-17.6	-223.4	--	130.9
BridgeBio Pharma (BBIO)	77.1	15,932.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	113.8	13,215.0	830.8	54.9	3.2	8.1	271.7	18.7
Dr. Reddy's Laboratories - ADR	12.1	10,087.6	332,834.2	33,166.6	11.1	8.9	28.8	2.5
Elanco Animal Health (ELAN)	24.1	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Ligand Pharmaceuticals (LGND)	279.9	5,707.4	290.5	197.2	82.5	19.9	29.6	5.9
Liquidia Technologies Inc (LQDA)	68.5	6,142.1	450.9	138.6	39.1	115.6	49	31.5
Twist Bioscience Corp (TWST)	141.4	9,129.6	431.8	-136.7	-30.8	-30.3	--	20.5

Shareholding Pattern

View Details

About Shuttle Pharmaceuticals Inc (SHPH)

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug... development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland. Read more

Co-Founder, CEO & Chairman of the Board

Dr. Anatoly Dritschilo M.D.
Co-Founder, CEO & Chairman of the Board

Dr. Anatoly Dritschilo M.D.
Headquarters

Gaithersburg, MD
Website

https://www.shuttlepharma.com

FAQs for Shuttle Pharmaceuticals Inc (SHPH)

What is the current share price of Shuttle Pharmaceuticals Inc (SHPH) Today?

The share price of Shuttle Pharmaceuticals Inc (SHPH) is $3.54 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Shuttle Pharmaceuticals Inc (SHPH) has given a return of -86.41% in the last 3 years.

What is the current PB & PE ratio of Shuttle Pharmaceuticals Inc (SHPH)?

The P/E ratio of Shuttle Pharmaceuticals Inc (SHPH) is 37.60 times as on 21-Aug-2026, a 1 premium to its peers’ median range of 37.31 times.
The P/B ratio of Shuttle Pharmaceuticals Inc (SHPH) is 0.67 times as on 21-Aug-2026, a 91 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.03	0.16
2024	-0.04	0.49
2023	-0.11	0.18
2022	-0.53	0.35
2021	--	--

What is the 52 Week High and Low of Shuttle Pharmaceuticals Inc (SHPH)?

The 52-week high and low of Shuttle Pharmaceuticals Inc (SHPH) are Rs 55.90 and Rs 2.58 as of 29-Aug-2026.

What is the market cap of Shuttle Pharmaceuticals Inc (SHPH)?

Shuttle Pharmaceuticals Inc (SHPH) has a market capitalisation of $ 2 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Shuttle Pharmaceuticals Inc (SHPH)?

Before investing in Shuttle Pharmaceuticals Inc (SHPH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.